Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.

By P. Arnison, M. Bibb, G. Bierbaum, A. Bowers, T. Bugni, G. Bulaj, J. Camarero, D. Campopiano, G. Challis, Jon Clardy and 55 more. Natural product reports (Print), 2013

1,606 citations recorded by the source corpus.

Subfields: Microbiology, Molecular Biology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/fa63b6f13372d931aff38cef82c0e6b9cbd67eba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Michael A. Fischbach
2. Marnix H. Medema
3. Oscar P. Kuipers
4. Eriko Takano
5. Anne de Jong
6. Jan Kok
7. Andrej Sali
8. Peter Cimermancic

In Pharmacology

1. Michael A. Fischbach
2. Marnix H. Medema
3. Eriko Takano
4. Jon Clardy
5. Tilmann Weber
6. Kai Blin

Citations in the corpus

• Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. (2014, background): “Another BGC class of unexpectedly large size is the ribosomally synthesized and posttranslationally modified peptides (RiPPs; Arnison et al., 2013).”
• A new genome-mining tool redefines the lasso peptide biosynthetic landscape (2016, methodology): “The unexpected prevalence of C-terminal Ser strongly correlates with the co-occurrence of a Ser kinase gene in several lasso peptide families, including the paeninodins 31 and yet-unexplored mesonodins and aneurinodins (Supplementary Tables 5–6), suggesting an O-phosphorylation site.”
• BAGEL4: a user-friendly web server to thoroughly mine RiPPs and bacteriocins (2018, background): “The post translational modifications in RiPPs expand the natural structural diversity beyond the 20 genetically encoded amino acids (1).”
• Bacteriocins of lactic acid bacteria: extending the family (2016, neutral): “Or glycocins Glycocins are bacteriocins containing glycosylated residue(s) (Arnison et al. 2013).”
• Small Molecules from the Human Microbiota (2015, neutral): “TOMMs are similar to microcin B17 in their biosynthesis and posttranslational modifications but encompass a larger family of natural products generated by both Gram-positive and Gramnegative bacteria (17, 42).”